Lataa...
Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers
Magnetic resonance imaging (MRI) of disease biomarkers, especially cancer biomarkers, could potentially improve our understanding of the disease and drug activity during preclinical and clinical drug treatment and patient stratification. MRI contrast agents with high relaxivity and targeting capabil...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4011496/ https://ncbi.nlm.nih.gov/pubmed/23335551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/wnan.1205 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|